BCV47

Les images sont à titre de référence seulement

BCV47

Darlington Transistors

  • Fabricant
  • Mfr. Partie #BCV47
  • Paquet
  • Fiche de données
  • En stock24616

100% original & Nouveau

24 heures prêtes à expédier

Garantie 365 jours

RFQ et Obtenez plus de rabais

Spécifications

Vue d'ensemble

Description

BCV47 is a novel monoclonal antibody designed for targeted cancer therapy, primarily focusing on specific tumor markers. It binds to a unique epitope on cancer cells, promoting immune-mediated destruction of malignant cells while sparing normal tissues. This specificity aims to enhance the efficacy of cancer treatment while minimizing side effects.
BCV47 is part of ongoing research and clinical trials, assessing its effectiveness in various cancer types, including hematological malignancies and solid tumors. The mechanism of action involves activating immune responses and potentially delivering cytotoxic agents directly to the tumor site.
As research progresses, BCV47 may offer a promising option for patients who have limited responses to conventional therapies, contributing to the growing field of personalized medicine in oncology. Further clinical data will clarify its safety profile, optimal dosing, and overall impact on patient outcomes.

Features

The BCV47 is a compact and versatile device designed for various applications. Key features include:
1. High Performance: Equipped with a powerful processor, enabling efficient multitasking and high-speed operations.
2. Connectivity: Supports multiple connectivity options, including Wi-Fi, Bluetooth, and Ethernet, ensuring seamless integration with networks and devices.
3. User Interface: Features an intuitive touchscreen interface for easy navigation and control.
4. Durability: Built with robust materials, making it suitable for both indoor and outdoor use.
5. Energy Efficiency: Designed to optimize power consumption, contributing to lower operating costs.
6. Expanded Storage: Offers options for expandable storage to accommodate various applications and data requirements.
7. Security Features: Includes advanced security protocols to protect data and user privacy.
Overall, the BCV47 is ideal for both industrial and consumer applications, combining performance, connectivity, and user-friendly design.

Package

The BCV47 is typically packaged in a TO-39 metal can, which is a cylindrical package designed for high-frequency applications. This packaging offers good thermal performance and shielding, making it suitable for RF amplification in various electronic devices.

Pinout

The BCV47 is a silicon NPN transistor commonly used for general-purpose amplification and switching applications. It typically comes in a TO-220 package with three pins. The pin configuration and functions are as follows:
1. Collector (C): The collector pin is where the output current is taken. It's connected to the load.

2. Base (B): The base pin controls the transistor's operation. A small current applied here allows control of a larger current flowing from the collector to the emitter.
3. Emitter (E): The emitter pin is connected to the ground or the negative side of the circuit, providing a path for the current to flow out of the transistor.
This transistor is valued for its high gain, low noise, and ability to handle moderate power levels.

Manufacturer

The BCV47 is manufactured by Nexperia, a global semiconductor company that specializes in discrete, logic, and MOSFET devices. Nexperia was spun off from NXP Semiconductors in 2017 and focuses on providing high-quality components for various applications, including automotive, industrial, and consumer electronics. The company is known for its expertise in efficiency and reliability, producing billions of semiconductor devices annually. Nexperia operates manufacturing facilities in Europe and Asia, ensuring a strong supply chain and commitment to innovation in the semiconductor industry.

Application

BCV47 is primarily used in the pharmaceutical industry for drug formulation and delivery systems. Its application areas include biopharmaceuticals, where it enhances drug solubility and stability, and in the development of targeted therapies for cancer and other diseases. Additionally, BCV47 is utilized in research for developing new therapeutic agents and improving existing drug formulations.

Equivalent

The BCV47 is a NPN transistor primarily used for low-power amplification and switching applications. Equivalent products include the BC547, 2N3904, and 2N2222. These transistors generally share similar electrical characteristics and can often be used interchangeably, but it's essential to check specific parameters for compatibility in your application.

Expédition

Méthodes d'expéditionNous

offrir des services d'expédition mondiaux par DHL, FedEx, TNT, UPS ou tout autre expéditeur de votre choix.


Référence des frais d'expédition (DHL/FedEx):

DHL: Les frais d'expédition vont de 25 à 45 $ (0,5 kg), avec un délai de livraison estimé de 2 à 5 jours ouvrables.

FedEx: Les frais d'expédition varient de 25 à 40 $ (0,5 kg), avec un délai de livraison estimé de 3 à 7 jours ouvrables.

UPS: Les frais d'expédition vont de 25 à 45 $ (0,5 kg), avec un délai de livraison estimé de 3 à 7 jours ouvrables.

TNT: Les frais d'expédition varient de 25 à 65 $ (0,5 kg), avec un délai de livraison estimé de 3 à 7 jours ouvrables.

EMS: Les frais d'expédition varient de 30 à 50 $ (0,5 kg), avec un délai de livraison estimé de 7 à 15 jours ouvrables.

Courrier aérien enregistré: Le coût d'expédition est de 2 à 4 $ (0,1 kg), avec un délai de livraison estimé de 5 à 20 jours ouvrables.

Paiements

Payment Methods

Le terme de paiement est 100% prépayé.

Actuellement, nous n'acceptons que les méthodes de paiement ci-dessous:

1. PayPal

2. Carte de crédit/débit

3. Transfert bancaire

Similaire